Kardiyovasküler Hastalıklarda Diyet Posasının Rolü

Yıl 2020, Cilt: 3 Sayı: 1, 1 - 10, 14.07.2020

Esra Uçar , Nural Erzurum Alim

Öz

Kardiyovasküler hastalıklar (KVH), dünya çapında genel ölüm nedenlerinde ilk sırada yer almaktadır. Her geçen yıl insidansı artmaktadır. KVH’ın nedenleri genetik ve çevresel faktörler olarak ikiye ayrılmaktadır. Çevresel faktörler arasında beslenme tipinin ve alışkanlıklarının rolü büyüktür. Doymuş yağ oranı yüksek ve posadan fakir beslenme tarzı yerine; vitamin, mineral ve diyet posasından zengin, meyve-sebze ve tahıl ürünlerinden oluşan beslenme şeklinin KVH’tan korunmada etkili olduğu bilinmektedir. Özellikle posadan zengin diyetin KVH üzerinde kan lipidlerini düşürücü, kan basıncını azaltıcı, insülin duyarlılığını artırıcı, inflamasyonu azaltıcı ve mikrobiyotayı değiştirici etkileri olduğu ortaya konmuştur. Çözünür posa, kardiyovasküler hastalıklar üzerinde daha etkili kan lipid yanıtları oluştururken; çözünmez posa, dolaylı yoldan olumlu etkiler göstermektedir. Posa kaynağı olan meyve-sebzeler, tam tahıllar, kuru baklagiller ve tohumlar ile oluşturulmuş dengeli bir diyet, kardiyovasküler hastalıkları önlemede hem ekonomik hem de etkili bir yöntem olabilir.

Anahtar Kelimeler

Beslenme, Diyet Posası, Kalp ve Damar Hastalıkları

Kaynakça

• 1. World Health Organization. [Internet]. Place unknown: Cardiovascular Diseases; 2017 [cited 2019 Oct 21]. Available from: https://www. who. int/news-room/fact- sheets/detail/cardiovascular-diseases-(cvds). 2. National Health Service. [Internet]. Place unknown: Atherosclerosis; 2019 [cited 2019 Oct 22] Available from: https://www.nhs. uk/conditions/Atherosclerosis/. 3. Zengin H. Pathogenesis of atherosclerosis. Journal of Experimental and Clinical Medicine [Internet]. 2012 Dec [cited 2020 Apr 06];29(3):101-106. Available from: https://dergipark.org.tr/en/download/article-file /190119. 4. Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet [Internet]. 2018 Nov [cited 2019 Oct 22]; 392: 1736-88. Available from: https://www.ncbi.nlm.nih.gov/pubmed /30496103. 5. Benjamin EJ et al. Heart disease and stroke statistics-2019 update: a report from the american heart association. Circulation [Internet]. 2019 Mar [cited 2019 Oct 22];139:56–528. Available from: https://www.aha journals.org/doi/10.1161/CIR.0000000000000659. 6. Chow CK, Islam S, Bautista L, Rumboldt Z, Yusufali A, Xie C, Anand SS, Engert JC, Rangarajan S, Yusuf S. Parental history and myocardial infarction risk across the world: the INTERHEART Study. J Am Coll Cardiol [Internet]. 2011Feb [cited 2019 Oct 22];57:619-627. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21272754. 7. Roth GA, Johnson CO, Abate KH, et al. The burden of cardiovascular diseases among US states, 1990–2016. JAMA Cardiol [Internet]. 2018 May [cited 2019 Oct 22];3:375-389. Available from:https://www.ncbi.nlm.nih.gov/pubmed/29641820. 8. Threapleton DE, Greenwood DC, Evans CE, et al. Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis. BMJ [Internet]. 2013 Dec [cited 2019 Oct 16];347:f6879. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24355537. 9. Hartley L, May MD, Loveman E, Colquitt JL, Rees K. Dietary fibre for the primary prevention of cardiovascular disease (review). Cochrane Database of Systematic Reviews [Internet]. 2016 Jan [cited 2019 Oct 16];7;(1):CD011472. doi: 10.1002/14651858.CD011472.pub2. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26758499. 10. Mirmiran P, Bahadoran Z, Moghadam SK, Vakili AZ and Azizi F. A prospective study of different types of dietary fiber and risk of cardiovascular disease: tehran lipid and glucose study. Nutrients [Internet]. 2016 Nov [cited 2019 Oct 16];8,686. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27827978. 11. American Association of Cereal Chemists. Definition of dietary fiber. Report of the dietary fiber definition committee to the board of directors of the american association of cereal chemists. Cereal Foods World [Internet]. 2001 Mar [cited 2019 Oct 17];46:112-26. Availablefrom:https://www.cerealsgrains.org/initiatives/defi nitions/Documents/DietaryFiber/DFDef.pdf. 12. Türkiye. Diyet Posası ve Beslenme. Posa kaynakları. Yayın No:727. Ankara: TC. Sağlık Bakanlığı; 2008. 13. Türkiye Beslenme Rehberi 2015 (TÜBER). Yağ asitleri, karbonhidrat ve posa için belirlenen referans değerler. Yayın No:1031. Ankara: Sağlık Bakanlığı; 2016. 14. Türkiye Beslenme Rehberi 2015 (TÜBER). Toplumda su, lif ve bazı mikro besin ögeleri alım miktarlarının, yeterli alım miktarları ile kıyaslanarak, bu besin ögelerinin yeterli alım durumunun değerlendirilmesi. Yayın No:1031. Ankara: Sağlık Bakanlığı; 2016. 15. Surampudi P, Enkhmaa B, Anuurad E, Berglund L. Lipid lowering with soluble dietary fiber. Curr Atheroscler Rep [Internet]. 2016 Dec [cited 2019 Oct 17];18:75. Available from: https://link.springer.com/article/10.1007%2Fs11883- 016-0624-z 16. Tayfur M. Beslenme ve Diyetetik Güncel Konular- 4: beta glukanın sağlık üzerine etkileri. Ankara: Tahir Hatipoğlu; 2016. 17. Whitehead A, Beck EJ, Tosh S, Wolever TM. Cholesterol lowering effects of oat beta-glucan: a meta-analysis of randomized controlled trials. Am J Clin Nutr [Internet]. 2014 Dec [cited 2019 Oct 20];100(6):1413–21. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25411276 18. Wang Y, Harding SV, Eck P, Thandapilly SJ, Gamel TH, el AbdelAal SM, et al. High-molecular-weight beta-glucan decreases serum cholesterol differentially based on the CYP7A1 rs3808607 polymorphism in mildly hypercholesterolemic adults. J Nutr [Internet]. 2016 Apr[cited 2019 Oct 20];146(4):720-7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26936139 19. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific opinion on the substantiation of a health claim related to oat beta-glucan and lowering blood cholesterol and reduced risk of (coronary) hearth disease pursuant to Article 14 of Regulation (EC) No1924/20061 EFSA Journal [Internet]. 2010 Dec [cited 2019 Nov 5];8(12):1885. Available from: https://www.efsa.europa.eu/en/efsajournal/pub/1885 20. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific opinion on the substantiation of a health claim related to barley beta-glucans and lowering blood cholesterol and reduced risk of (coronary) hearth disease pursuant to Article 14 of Regulation (EC) No1924/20061 2,3 EFSA Journal [Internet]. 2011 Dec [cited 2019 Nov 5];9(12):2471. Available from: https://www.efsa.europa.eu/en/efsajournal/pub/2470 21. Ribas SA, Cunha DB, Sichieri R, da Silva SLC. Effects of psyllium on LDL-cholesterol concentrations in Brazilian children and adolescents: a randomised, placebo-controlled, parallel clinical trial. Br J Nutr [Internet]. 2015 Jan [cited 2019 Oct 20];113(1):134-41. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25391814 22. Jovanovski E, Yashpal E, Komishon A, Zurbau A, Mejia SB, Ho HVT, Li D, Sievenpiper J, Duvnjak L, Vuksan V. Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein b: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr [Internet]. 2018 Nov [cited 2019 Oct 20];108:1–11. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30239559 23. Food and Drug Administration [Internet]. U.S Department of Health and Human Services; 2019 Apr [cited 2019 Oct 20]; [Code of Federal Regulations Title 21, Volume 2]. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CF RSearch.cfm?fr=101.81 24. Van der Gronde T, Hartog A, van Hees C, Pellikaan H, Pieters T. Systematic review of the mechanisms and evidence behind the hypocholesterolaemic effects of HPMC, pectin and chitosan in animal trials. Food Chem [Internet]. 2016 May [cited 2019 Oct 20];199:746–59. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26776032 25. Anderson JW, Baird P, Davis J, Ferreri S, Knudtson M, Koraym A. et al. Health benefits of dietary fiber. Nutrition Reviews [Internet]. 2009 Apr [cited 2020 Apr 01];67,188- 205. Available from: https://pubmed.ncbi.nlm.nih.gov/19335713/ 26. Brouns F, Theuwissen E, Adam A, Bell M, Berger A, Mensink RP. Cholesterol-lowering properties of different pectin types in mildly hyper-cholesterolemic men and women. European Journal of Clinical Nutrition [Internet]. 2012 May [cited 2020 Apr 01];66,591-599. Available from: https://pubmed.ncbi.nlm.nih.gov/22190137/ 27. European Food Safety Authority (EFSA). Scientific Opinion on the substantiation of health claims related to pectins and reduction of post-prandial glycaemic responses, maintenance of normal blood cholesterol concentrations and increase in satiety leading to a reduction in energy intake. EFSA Journal [Internet]. 2010 Jul [cited 2020 Apr 01];8(10),1747.Available from: https://efsa.onlinelibrary.wiley. com/doi/pdf/10.2903/j.efsa.2010.1747. 28. Jang AL, Hwang SK, Kim DU. Effects of guar gum ingestion on postprandial blood pressure in older adults. The Journal of Nutrition, Health and Aging [Internet]. 2015 Mar [cited 2019 Oct 20];19(3),299-304. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25732215 29. Besten G, Gerding A, van Dijk TH, Ciapaite J, Bleeker A, van Eunen K, et al. Protection against the metabolic syndrome by guar gum-derived short-chain fatty acids depends on peroxisome proposaerator-activated receptor gamma and glucagon-like peptide-1. PLoS One [Internet]. 2015 Aug [cited 2019 Oct 20];10(8):e0136364. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26292284 30. Hartvigsen ML, Laerke HN, Overgaard A, Holst JJ, Bach Knudsen KE, Hermansen K. Postprandial effects of test meals including concentrated arabinoxylan and whole grain rye in subjects with the metabolic syndrome: a randomised study. Eur J Clin Nutr [Internet]. 2014 May [cited 2019 Oct 20];68(5):567-74. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24595224 31. Hald S, Schioldan AG, Mary E. ME, Dige A, HN, Agnholt J, Knudsen KEB, Hermansen K, Marco ML, Gregersen S, Dahlerup JF. Effects of arabinoxylan and resistant starch on ıntestinal microbiota and short-chain fatty acids in subjects with metabolic syndrome: a randomised crossover study. Plos One [Internet]. 2016 Jul [cited 2019 Oct 20];(11)7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27434092 32. Salazar N, Dewulf EM, Neyrinck AM, Bindels LB, Cani PD, Mahillon J, et al. Inulin-type fructans modulate intestinal bifidobacterium species populations and decrease fecal short chain fatty acids in obese women. Clin Nutr [Internet]. 2015 Jun [cited 2019 Oct 20];34(3):501-7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24969566 33. Kumar V, Sınha AK, Makkar HPS, De Boeck G, Becker K. Dietary roles of non-starch polysachharides in human nutrition: a review. Crit Rev Food Sci Nutr [Internet]. 2012 Jul [cited 2019 Oct 23]; 52:899–935. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22747080 34. Moreno FB, Leon LM, Andres EEM, Ordovas JM, Casanovas JA, Penalvo JL. Soluble and insoluble dietary fibre intake and risk factors for metabolic syndrome and cardiovascular disease in middle- aged adults: the AWHS cohort. Nutr Hosp [Internet]. 2014 Dec [cited 2019 Oct 22];1:30(6):1279-88. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25433109 35. McRae MP. Dietary fiber ıs beneficial for the prevention of cardiovascular disease: an umbrella review of meta-analyses. Journal of Chiropractic Medicine [Internet]. 2017 Dec [cited 2019 Oct 17];1556- 3707. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29276461 36. Vitale M, Masulli M, Cocozza S, Anichini R, Babini AC, Boemi M, Bonora E, Buzzetti R, Carpinteri R, Caselli C et al. Sex differences in food choices, adherence to dietary recommendations and plasma lipid profile in type 2 diabetes e The TOSCA.IT study. Nutr. Metab. Cardiovasc. Dis [Internet]. 2016 Oct [cited 2019 Oct 17];26, 879–885. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27212622 37. Aljuraiban GS, Griep LMO, Chan Q, Daviglus ML, Stamler J, Van HL, Elliott P, Frost GS. Total, insoluble and soluble dietary fibre intake in relation to blood pressure: The INTERMAP Study. Br. J. Nutr [Internet]. 2015 Nov [cited 2019 Oct 17];114, 1480–1486. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26328746 38. Wu Y, Qian Y, Pan Y, Li P, Yang J, Ye X, Xu G. Association between dietary fibre intake and risk of coronary heart disease: A meta-analysis. Clin. Nutr [Internet]. 2015 Aug [cited 2019 Oct 17];34, 603-611. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24929874 39. Ning H, Van Horn L, Shay C.M, Lloyd-Jones DM, Associations of dietary fibre intake with long-term predicted cardiovascular disease risk and c-reactive protein levels from the NHANES data. Am. J. Cardiol [Internet]. 2014 Jan [cited 2019 Oct 17];113,287-291. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24176070 40. Kim Y, Je Y. Dietary fibre intake and mortality from cardiovascular disease and all cancers: A meta-analysis of prospective cohort studies. Arch. Cardiovasc. Dis [Internet]. 2016 Jan [cited 2019 Oct 17];109,39-54. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26711548 41. Xu H, Huang X, Riserus U, et al. Dietary fiber, kidney function, inflammation, andmortality risk. Clin J Am Soc Nephrol [Internet]. 2014 Dec [cited 2019 Oct 17];9(12):2104- 2110. Available from: https://www.ncbi.nlm. nih.gov/pubmed/25280496. 42. Gaskins AJ, Mumford SL, Rovner AJ, et al. Whole grains are associated with serum concentrations of high sensitivity c- reactive protein among premenopausal. women. J Nutr [Internet]. 2010 Sep [cited 2019 Oct 17];140(9):1669-1676. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC2924598/. 43. Goletzke J, Buyken AE, Joslowski G, et al. Increased intake of carbohydrates from sources with a higher glycemic index and lower consumption of whole grains during puberty are prospectively associated with higher IL-6 concentrations in younger adulthood among healthy individuals. J Nutr [Internet]. 2014 Oct [cited 2019 Oct 17];144(10):1586-1593. Available from: https://www.ncbi.nlm.nih. gov/pubmed/25080538. 44. Wang H, Lichtenstein AH, Lamon-Fava S and Jacques PF. Association between statin use and serum cholesterol concentrations is modified by whole-grain consumption. Am J Clin Nutr [Internet]. 2014 Oct [cited 2019 Oct 22];100:1149–57. Available from: https://www.ncbi. nlm.nih.gov/pubmed/?term=Association+between+statin+us e+and+serum+cholesterol+concentrations+is+modified+by+ whole-grain+ consumption. 45. Bozzetto L, Costabile G, Pepa GD, Ciciola P, Vetrani C, Vitale M, Rivellese AA, Annuzzi G. Dietary fibre as a unifying remedy for the whole spectrum of obesity- associated cardiovascular risk. Nutrients [Internet]. 2018 Jul [cited 2019 Oct 17];10,943. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30037123. 46. Karl JP, Saltzman E. The role of whole grains in body weight regulation. Adv. Nutr [Internet]. 2012 Sep [cited 2019 Oct 17];3,697-707. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22983848. 47. Vetrani C, Costabile G, Luongo D, Naviglio D, Rivellese AA, Riccardi G, Giacco R. Effects of whole-grain cereal foods on plasma short chain fatty acid concentrations in individuals with the metabolic syndrome. Nutrition [Internet]. 2016 Feb[cited 2019 Oct 17];32,217-221. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26706023. 48. Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat. Rev. Endocrinol [Internet]. 2015 Oct [cited 2019 Oct 17];11,577-591. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26260141 . 49. Harris K, Kassis A, Major G, Chou CJ. Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? J. Obes [Internet]. 2012 Jan [cited 2019 Oct 17];879151. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22315672. 50. Caricilli AM, Saad MJ. The role of gut microbiota on insulin resistance. Nutrients [Internet]. 2013 Mar [cited 2019 Oct 17];5,829-851. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23482058. 51. Ning H, Van Horn L, Shay CM, Lloyd-Jones DM. Associations of dietary fiber intake with long-term predicted cardiovascular disease risk and c-reactive protein levels (from the National Health and Nutrition Examination Survey Data [2005-2010]). Am J Cardiol [Internet]. 2014 Jan [cited 2020 Apr 01];113(2):287-291. Available from: https://pubmed.ncbi.nlm.nih.gov/24176070/. 52. Richter WO, Jacob BG, Schwandt P. Interaction between fibre and lovastatin. Lancet [Internet]. 1991 Sep [cited 2019 Oct 20];338(8768):706. Available from: https://www.ncbi.nlm.nih. gov/pubmed/1679514. 53. Fugh-Berman A. Herb-drug interactions. Lancet [Internet]. 2000 Jan [cited 2019 Oct 20];355(9198):134-8. Available from: https://www. ncbi.nlm.nih.gov/pubmed/10675182